Quotient Sciences
Clinical Trial Alerts
Never miss a Quotient Sciences clinical trial. Get instant alerts for new studies in Nottingham, including phase 1 trials and bioequivalence studies.
Get Quotient Trial Alerts →About Quotient Sciences
Quotient Sciences is a global pharmaceutical development company that accelerates the development of new drugs through their integrated Translational Pharmaceutics® platform. With state-of-the-art facilities in Nottingham, UK, and additional locations worldwide, Quotient Sciences is a leader in early-phase clinical research.
What Makes Quotient Sciences Unique?
- Integrated Platform: Combines formulation development with clinical testing for faster drug development
- World-Class Facilities: Purpose-built clinical research unit in Nottingham with 100+ bed capacity
- Experienced Team: Expert clinicians, scientists, and support staff dedicated to participant safety
- Global Reputation: Trusted by pharmaceutical companies worldwide for drug development
Types of Clinical Trials at Quotient Sciences
Phase 1 Clinical Trials
First-in-human studies testing new drugs for safety and tolerability. These trials help researchers understand how the body processes new medications.
- • Single Ascending Dose (SAD) studies
- • Multiple Ascending Dose (MAD) studies
- • First-in-human trials
- • Safety and tolerability assessments
Bioequivalence Studies
Comparing different formulations of medications to ensure they work the same way in the body. Critical for generic drug development.
- • Generic vs. brand comparison
- • Formulation studies
- • Crossover design trials
- • Relative bioavailability studies
Food Effect Studies
Testing how food consumption affects drug absorption and effectiveness. Helps determine dosing instructions.
- • Fed vs. fasted comparisons
- • Meal timing studies
- • Pharmacokinetic assessments
Drug Interaction Studies
Examining how different medications interact when taken together, ensuring safe use with other treatments.
- • Drug-drug interaction trials
- • Combination therapy studies
- • Safety monitoring
Participating in Quotient Sciences Trials
💰 Compensation
Quotient Sciences trials typically offer competitive compensation for participants' time and contribution to medical research. Payment varies based on the study duration, number of visits, and complexity of the trial. Many participants find clinical trials to be a flexible way to earn income while contributing to medical advancement.
What to Expect
- Screening Visit: Initial health checks to determine eligibility for the study
- Confinement Periods: Many trials require staying at the facility for several days for close monitoring
- Comfortable Accommodation: Private or shared rooms with entertainment, WiFi, and meals provided
- Regular Monitoring: Blood samples, vital signs, and safety assessments throughout the study
- Follow-up Visits: Additional check-ups after the main study period
Why Use Trial Announcer for Quotient Sciences Trials?
Quotient Sciences trials are highly sought after due to their professional environment, competitive compensation, and excellent facilities. Studies often fill within hours or even minutes of being posted. Trial Announcer gives you the competitive edge you need.
How Trial Announcer Helps You:
- ⚡Instant Notifications:
Get alerts the moment a new Quotient Sciences trial is posted, before it appears on their website
- 🎯Smart Matching:
Only receive alerts for trials you're eligible for based on age, BMI, gender, and other criteria
- 🏆Priority Access:
Pro users get notified 15 minutes early, Enterprise users get instant alerts
- 📱Multi-Channel Alerts:
Receive notifications via Discord, Telegram, Email, or Push notifications
💡 Success Tip
Many Trial Announcer users report successfully securing Quotient Sciences trials thanks to our early alert system. The difference between being first and being tenth in line can mean the difference between acceptance and waitlist. Our Enterprise plan gives you the maximum competitive advantage with instant notifications.
Start Getting Quotient Sciences Trial Alerts
Be among the first to know when new trials open